Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.33 |
| ▸ | MAP2K1 | Q02750 | 2/20 | 0.31 |
| ▸ | ANO1 | Q5XXA6 | 1/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4449620 | 1.00 | MRGPRX4 (0.33) | MRGPRX4MAP2K1ANO1SIGMAR1 | |
| SCHEMBL4448034 | 0.88 | GRIN2B (0.33) | — | |
| SCHEMBL4448032 | 0.88 | GRIN2B (0.33) | — | |
| SCHEMBL19742850 | 0.83 | SCN9A (0.34) | — | |
| SCHEMBL157046 | 0.81 | SCN9A (0.38) | — | |
| SCHEMBL121354 | 0.81 | SCN9A (0.38) | — | |
| SCHEMBL29485704 | 0.81 | SCN9A (0.38) | — | |
| SCHEMBL1278450 | 0.81 | SCN9A (0.38) | — | |
| SCHEMBL21779547 | 0.81 | SLC6A2 (0.41) | — | |
| SCHEMBL12710204 | 0.80 | RHEB (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090018176-A1 | FUNGICIDE COMPOSITION COMPRISING AN ARYLAMIDINE DERIVATIVE AND TWO KNOWN FUNGICIDE COMPOUNDS | BAYER CROPSCIENCE AG (DE) | 2009-01-15 | — | — | US | claimed |
| US-20070155802-A1 | Fungicide composition comprising an arylamidine derivative and known fungicide compounds | BAYER CROPSCIENCE S.A. (FR) | 2007-07-05 | — | — | US | claimed |
| EP-1424893-B1 | FUNGICIDAL MIXTURE CONTAINING ARYLAMIDINE DERIVATIVES | BAYER CROPSCIENCE SA (FR) | 2006-04-19 | — | — | EP | claimed |
| EP-1570736-A1 | Fungicide composition comprising an arylamidine derivative and known fungicide compounds | Bayer CropScience S.A. (FR) | 2005-09-07 | — | — | EP | claimed |
| US-20090018176-A1 | FUNGICIDE COMPOSITION COMPRISING AN ARYLAMIDINE DERIVATIVE AND TWO KNOWN FUNGICIDE COMPOUNDS | BAYER CROPSCIENCE AG (DE) | 2009-01-15 | — | — | US | disclosed |
| US-20070155802-A1 | Fungicide composition comprising an arylamidine derivative and known fungicide compounds | BAYER CROPSCIENCE S.A. (FR) | 2007-07-05 | — | — | US | disclosed |
| EP-1424893-B1 | FUNGICIDAL MIXTURE CONTAINING ARYLAMIDINE DERIVATIVES | BAYER CROPSCIENCE SA (FR) | 2006-04-19 | — | — | EP | disclosed |
| EP-1570736-A1 | Fungicide composition comprising an arylamidine derivative and known fungicide compounds | Bayer CropScience S.A. (FR) | 2005-09-07 | — | — | EP | disclosed |
| US-20040241098-A1 | Fungicidal mixture containing arylamidine derivatives | BAYER CROPSCIENCE S.A. (FR) | 2004-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090018176-A1 | FUNGICIDE COMPOSITION COMPRISING AN ARYLAMIDINE DERIVATIVE AND TWO KNOWN FUNGICIDE COMPOUNDS | NAT1, DDT, CNPY2 | MRGPRX4 2604/4885MAP2K1 3935/4885ANO1 2235/4885 |
| US-20070155802-A1 | Fungicide composition comprising an arylamidine derivative and known fungicide compounds | PFN1, CNPY2, PRDX1 | MRGPRX4 716/4885MAP2K1 4496/4885ANO1 1586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.